TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Lancet Series on access to and sustainable effectiveness of antimicrobials

The Lancet
Jan. 9, 2016, 7:34 p.m.
post image

The Lancet published a Series of five papers examining access to and sustainable effectiveness of antimicrobials.

The first two papers provide an insight into the mechanisms and drivers of antimicrobial resistance, its disease burden, and the potential effect of vaccines in restricting the need for antibiotics. The last three papers in the Series examine access and sustainability of antimicrobials at a more geographical level: reviewing access in low-income and middle-income countries; considering different policy domains and their effectiveness at national and regional levels to combat resistance; and identifying gaps in the current global effort to improve international collaboration and achieve key policy goals.

Download the Series papers here:

Access to effective antimicrobials: a worldwide challenge

Understanding the mechanisms and drivers of antimicrobial resistance

Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

Exploring the evidence base for national and regional policy interventions to combat resistance

International cooperation to improve access to and sustain effectiveness of antimicrobials

Download comments on the Series papers here:

Antibiotics: achieving the balance between access and excess

Animal production and antimicrobial resistance in the clinic

National action for global gains in antimicrobial resistance


Source: The Lancet